Corporate news

Grifols opens new plasma fractionation plant in Spain The company has invested over 20 million euros, doubling its plasma fractionation capacity in Spain
+ info

Japanese Red Cross selects Grifols as partner for nucleic acid screening of nation's blood supply Japanese Red Cross will use the Procleix® Panther® platform to screen approximately 5.3 million blood donations each year for HIV and Hepatitis viruses
+ info

Grifols' sales rose by 4.6% to Euros 2,741.7 million In 2013 Grifols maintained its position as the third largest producer of plasma derivatives
+ info



We are a solid company with an international dimension.

Corporate Commitment

We contribute to improving people's health and wellbeing by offering safe, high quality products produced using the latest environmentally friendly technology.

banner a awards Martín VillarMartín Villar Haemostasis Awards

Grifols is holding the seventh edition of the Martin Villar Awards for Research in Haemostasis. + info


get to know us better

2012 Awards Martí Villar